Ovid Therapeutics (OVID)
(Delayed Data from NSDQ)
$0.93 USD
-0.03 (-2.93%)
Updated Aug 5, 2024 04:00 PM ET
After-Market: $0.94 +0.01 (0.86%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Brokerage Reports
0 items in cart
Ovid Therapeutics [OVID]
Reports for Purchase
Showing records 1 - 11 ( 11 total )
Company: Ovid Therapeutics
Industry: Medical - Biomedical and Genetics
OV888 Yields Positive Phase 1 Data; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Ovid Therapeutics
Industry: Medical - Biomedical and Genetics
OV888 Update Arrives As Anticipated, Moving To Phase 2
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Ovid Therapeutics
Industry: Medical - Biomedical and Genetics
Restructuring Not Unexpected, Looking Ahead To OV329
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Ovid Therapeutics
Industry: Medical - Biomedical and Genetics
Soticlestat Misses Mark; Pipeline Retains Value; Lowering PT to $3
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Ovid Therapeutics
Industry: Medical - Biomedical and Genetics
Taking Out Soticlestat, But Sticking With OVID and OV329
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Ovid Therapeutics
Industry: Medical - Biomedical and Genetics
Soticlestat Pivotal Data Approaching; 1Q24 Financials; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Ovid Therapeutics
Industry: Medical - Biomedical and Genetics
Why OVID''s Worth A Look -- Near-Term Catalysts For One
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Ovid Therapeutics
Industry: Medical - Biomedical and Genetics
Revolutionizing Treatment for CNS Disorders; Initiating at Buy and $9 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Ovid Therapeutics
Industry: Medical - Biomedical and Genetics
Company: Ovid Therapeutics
Industry: Medical - Biomedical and Genetics
We are initiating coverage with an Outperform rating and $8 target.
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Ovid Therapeutics
Industry: Medical - Biomedical and Genetics
|